344 related articles for article (PubMed ID: 17540403)
1. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
[TBL] [Abstract][Full Text] [Related]
2. Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation.
Liou JY; Lee S; Ghelani D; Matijevic-Aleksic N; Wu KK
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1481-7. PubMed ID: 16645156
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells.
Lin H; Lee JL; Hou HH; Chung CP; Hsu SP; Juan SH
J Cell Physiol; 2008 Feb; 214(2):434-41. PubMed ID: 17620284
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes.
Li L; Wu L; Wang C; Liu L; Zhao Y
Regul Pept; 2007 Mar; 139(1-3):72-9. PubMed ID: 17109977
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart.
Cook GA; Edwards TL; Jansen MS; Bahouth SW; Wilcox HG; Park EA
J Mol Cell Cardiol; 2001 Feb; 33(2):317-29. PubMed ID: 11162136
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG
Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
9. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
10. Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element.
Barrero MJ; Camarero N; Marrero PF; Haro D
Biochem J; 2003 Feb; 369(Pt 3):721-9. PubMed ID: 12408750
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells.
Julan L; Guan H; van Beek JP; Yang K
Endocrinology; 2005 Mar; 146(3):1482-90. PubMed ID: 15591138
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth.
Fukumoto K; Yano Y; Virgona N; Hagiwara H; Sato H; Senba H; Suzuki K; Asano R; Yamada K; Yano T
FEBS Lett; 2005 Jul; 579(17):3829-36. PubMed ID: 15978581
[TBL] [Abstract][Full Text] [Related]
15. Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.
Sharma V; Dhillon P; Parsons H; Allard MF; McNeill JH
Eur J Pharmacol; 2009 Apr; 607(1-3):156-66. PubMed ID: 19233164
[TBL] [Abstract][Full Text] [Related]
16. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.
Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT
Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863
[TBL] [Abstract][Full Text] [Related]
17. Effects of dietary fatty acid composition on the regulation of carnitine palmitoyltransferase (CPT) I in rainbow trout (Oncorhynchus mykiss).
Morash AJ; Bureau DP; McClelland GB
Comp Biochem Physiol B Biochem Mol Biol; 2009 Jan; 152(1):85-93. PubMed ID: 18992836
[TBL] [Abstract][Full Text] [Related]
18. Carbaprostacyclin, a PPARdelta agonist, ameliorates excess lipid accumulation in diabetic rat placentas.
Kurtz M; Capobianco E; Martínez N; Fernández J; Higa R; White V; Jawerbaum A
Life Sci; 2010 May; 86(21-22):781-90. PubMed ID: 20338185
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts.
Liang YJ; Chen CY; Juang SJ; Lai LP; Shyu KG; Wang BW; Liu SY; Leu JG
Eur J Pharmacol; 2010 Sep; 643(1):84-92. PubMed ID: 20599914
[TBL] [Abstract][Full Text] [Related]
20. PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells.
Thulin P; Glinghammar B; Skogsberg J; Lundell K; Ehrenborg E
Int J Mol Med; 2008 Jun; 21(6):819-24. PubMed ID: 18506377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
